Central pain processing and modulation biomarkers profile in chronic pain prediction in patients with cancer
- Conditions
- Cancer
- Registration Number
- ISRCTN14475880
- Lead Sponsor
- IPO Porto
- Brief Summary
2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38849731/ (added 10/06/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 450
1. Adult subjects =18 years old
2. Able to provide informed consent to participate in the study
3. Able to self-report pain
4. Recent diagnosis (less than 6 months) of cancer affecting the lung, breast, pancreas or colon (with metastases or not)
5. Not having started cancer treatment (all treatments are included)
6. Have a life expectancy of at least 12 months
7. Ability to use the internet and WhatsApp or have a person (family member, caregiver) to help them
1. Pregnant women or women of fertile age not having efficacious contraception during the whole period of the study
2. Neurological and psychiatric disease (except anxiety and depression)
3. Unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure or chronic obstructive pulmonary disease)
4. History of neurosurgery, traumatic brain injury with loss of consciousness, and/or cortical lesions
5. History of non-malignant chronic pain
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method